No Result
View All Result
  • Login
  • Home
  • Shop
  • News
    • All News
    • World Diabetes Day
    • World Health Day
    • World Heart Day
    • World Kidney Day
    • World Obesity Day
  • Know How
    Basics
    Excipients
    Production Process
    Excipient Selection in Nutraceuticals
    Formulation in Nutraceuticals
    Product Development in Nutraceuticals
    Packaging in Nutraceuticals
    Sourcing in Nutraceuticals
    Ingredients & Supplements
    Fibers & Carbohydrates
    Herbs & Botanicals
    Lipids & Essential Fatty Acids
    Marine Ingredients & Omega 3s
    Probiotics & Prebiotics
    Proteins & Amino Acids
    Speciality Nutrients
    Vitamins & Minerals
    • Basics
    • Excipients
    • Production Process
      • Introduction to Excipient Selection in Nutraceuticals
      • Introduction to Formulation in Nutraceuticals
      • Introduction to Product Development in Nutraceuticals
      • Introduction to Packaging in Nutraceuticals
      • Introduction to Sourcing in Nutraceuticals
    • Ingredients & Supplements
      • Fibers & Carbohydrates
      • Herbs & Botanicals
      • Lipids & Essential Fatty Acids
      • Marine Ingredients & Omega 3s
      • Probiotics & Prebiotics
      • Proteins & Amino Acids
      • Speciality Nutrients
      • Vitamins & Minerals
  • Applications
    • Capsules
    • Effervescent
    • Granules
    • Gummy
    • Lozenges
    • Oral Thin Films
    • Sachets
    • Soft Capsules
    • Tablets
  • Sectors
    • Bone & Joint Health
    • Brain Health
    • Cardiovascular Health
    • Immunity & Gut Health
    • Sports Nutrition
    • Weight Management & Metabolism Support
  • Sourcing

    Suppliers
    Antares Health Products
    Biogrund
    DFE Pharma
    Dr. Paul Lohmann
    JRS Pharma
    Magnesia
    Roquette
    Consultants

    • Suppliers
      • Biogrund – Film Coating Excellence
      • DFE Pharma
      • JRS Pharma
      • Magnesia
      • Roquette
    • Consultants
  • Webinars
Pharma Excipients
All4Nutra
All4Nutra
No Result
View All Result

Home » News » Cognitive and Mood Ingredients at SupplySide Global 2026: Recap

Events Herbs & Botanicals Ingredients & Supplements Innovations News Probiotics & Prebiotics SupplySide Global
| 5. November 2026

Cognitive and Mood Ingredients at SupplySide Global 2026: Recap

Cognitive Health

Cognitive Health

Cognitive health and mood ingredients at SupplySide Global 2026 (Mandalay Bay, Las Vegas, expo October 28 to 30) clustered around three ideas: low-dose, non-stimulant botanicals with acute-onset data, gut-brain biotics, and a collagen peptide composition its supplier describes as the first designed for cognition [1,7]. The All4Nutra team photographed nine exhibitors in the category: Givaudan (Cereboost and Zensera), Stratum Nutrition (sageXtra), Seppic (Sepibright), Kyowa Hakko (Cognizin and Setria), Rousselot (Nextida NxCogni), Unique Biotech (Cognisol), Bereum (beLP1), Nutraland USA (Vegadelight), and Herbal Treasure (private-label mushroom gummies). Most showcased doses sit between 10 mg and 500 mg per day, low enough for one capsule, one stick pack, or one or two gummies [2,6,8,13]. The evidence behind the booth claims is often narrower than the signage suggests. In the published trials of Zensera, Sepibright, and Cognizin, the primary outcome did not differ from placebo, and the positive results came from secondary or exploratory endpoints [2,6,8]. Most trials located for these ingredients were small and supplier-funded or supplier-authored [2,3,6,8,12,13]. For formulators, three questions follow: which outcome a claim rests on, whether the tested dose matches the label dose, and how the active behaves in the chosen format.

Table of contents

  • What defined cognitive and mood ingredients at SupplySide Global 2026
  • How the showcased cognitive and mood ingredients compare
  • Exhibitor highlights: companies and showcased products
  • Formulation considerations for low-dose cognitive actives
  • What claims cognitive and mood ingredients can carry in the US and EU
  • Frequently asked questions
  • Key takeaways
  • Sources

What defined cognitive and mood ingredients at SupplySide Global 2026

Cognitive and mood ingredients at SupplySide Global 2026 shared a product brief: work within hours, avoid stimulants, and fit a small serving. Two booths promoted time-to-effect directly, on three products. Givaudan’s Cereboost card read “1 hour caffeine-free boost”, its Zensera card “5 hrs support for cognitive performance under stress”, and Stratum Nutrition’s sageXtra flyer promised support for memory and attention “in as little as 1 hour” without caffeine. That framing suits day-part products, such as a morning focus stick or an afternoon stress gummy, more than long-term brain-aging formulas.

 

 

1 of 4
- +
Givaudan at Supply Side Global 2026
Stratum Sagextra

The second cluster sits on the gut-brain axis. Unique Biotech presented Cognisol as a “psychobiotic” probiotic blend, and Bereum presented beLP1 as a heat-treated postbiotic with “gut health” and “mood support” on the same panel. The education programme reflected the same pairing, with an October 27 session on brain-gut harmony and mood foods and an October 28 session on sleep and stress solutions [1].

 

1 of 2
- +
Product belP1 by ...at Supply Side Global 2026

The third cluster is new ingredient classes moving into cognition:

  • Collagen peptides, with Rousselot’s Nextida NxCogni and an October 29 session on cognitive clarity from collagen peptides [1,7].
  • Upcycled leaf extracts, with Seppic’s strawberry leaf extract Sepibright [6].
  • Finished-format private label, with mushroom gummies, mushroom cocoa, and mushroom coffees from Herbal Treasure [18].

 

1 of 3
- +

Magtein magnesium L-threonate appeared on aisle banners and in an October 28 breakfast brief, and a bacopa session closed the programme on October 30 [1]. All4Nutra’s guide to nootropic ingredients such as citicoline, bacopa, and lion’s mane covers the substance background.

See our short video from Supply Side Global 2026 with Magtein here:

http://www.all4nutra.com/wp-content/uploads/2026/11/Magtein-at-Supply-Side-Global.mp4

How the showcased cognitive and mood ingredients compare

The showcased ingredients differ less in dose than in the depth of their human evidence, as Table 1 shows.

Table 1. Cognitive and mood ingredients photographed at SupplySide Global 2026: dose and human evidence

Ingredient (exhibitor) Type Dose shown or tested Human evidence located Key finding and caveat
Cereboost (Givaudan) Panax quinquefolius root extract 200 mg per capsule, 1 to 2 capsules/day [4] Acute crossover, n = 32 [3] Working memory improved at 1, 3, and 6 h; supplier-funded [3]
Zensera (Givaudan) Melissa officinalis leaf extract 300 mg, single dose [2] Acute RCT, n = 106 [2] Primary outcome (calmness) unchanged; task switching better at 3 and 5 h [2]
sageXtra (Stratum Nutrition) Salvia officinalis extract 167 mg (flyer); 333 mg most consistent in trial [5] Sage extract class data (extract not identified as sageXtra): acute crossover, n = 20 [5] 333 mg improved secondary memory and attention; other doses less so [5]
Sepibright (Seppic) Fragaria Ă— ananassa leaf extract 300 mg/day, 12 weeks [6] RCT, 109 randomized [6] No treatment-by-time effect on primary outcome; exploratory memory signal [6]
Cognizin (Kyowa Hakko) Citicoline 500 mg/day, 12 weeks [8] RCT, n = 100 [8] Primary outcome unchanged; episodic memory (secondary) improved [8]
Nextida NxCogni (Rousselot) Collagen peptides Not disclosed [7] None published [7] Preclinical only; open-label study planned from December 2026 [7]
Cognisol (Unique Biotech) Six-strain probiotic plus L-glutamine 20 billion CFU/day in trial [12] RCT, n = 80 students [12] Stress scores and serum cortisol lower than placebo [12]
beLP1 (Bereum) Heat-treated Lactiplantibacillus plantarum 10 mg/day (at least 30 billion cells) [13] RCT, 140 randomized [13] Gut symptoms (primary) and perceived stress (secondary) improved [13]
Vegadelight (Nutraland USA) Lichen vitamin D3 Grade-dependent [15] Vitamin D3 class data [16] 2,000 IU/day did not lower depression risk in adults 50 and over [16]
Mushroom gummies (Herbal Treasure) Mushroom extracts Per-gummy dose not stated [18] Lion’s mane pilot, n = 41 [19] Faster Stroop at 60 min with 1.8 g; small pilot [19]

CFU: colony-forming units. RCT: randomized controlled trial.

Exhibitor highlights: companies and showcased products

Givaudan: Cereboost American ginseng and Zensera lemon balm

Givaudan grouped Cereboost and Zensera on a “Cognitive Health” pedestal, with a Cereboost “Focus Bites” gummy jar, a “Brain On” sample box, and dried ginseng root on display. Cereboost is an American ginseng (Panax quinquefolius) root extract. Health Canada licenses it at 200 mg per capsule, a 4:1 extract equal to 800 mg dried root, for working memory, attention, and reduced mental fatigue in healthy individuals [4]. The “1 hour” claim traces to a crossover trial in 32 healthy young adults, in which 100, 200, and 400 mg improved a working-memory task at 1, 3, and 6 hours; Naturex, the extract’s original developer, funded it [3].

Zensera is a lemon balm (Melissa officinalis) leaf extract made by a patent-pending process. In its trial, 106 young adults with moderate perceived stress took one 300 mg dose or maltodextrin before demanding cognitive batteries [2]. Overall calmness, the primary outcome, did not differ from placebo. Task-switching accuracy was higher with Zensera at 3 and 5 hours, although the groups already differed on this measure at baseline, and Givaudan funded the study [2]. The booth’s other pedestals covered metabolic health (Novaberin, OatWell, Svetol, and Glucevia) and muscle and mobility (Lifenol and TurmiPure Gold).

Stratum Nutrition: sageXtra sage extract

Stratum Nutrition presented sageXtra, a Salvia officinalis extract, on a B2B flyer titled “Fast and Flexible Cognitive Support”. The flyer positions it as a non-stimulant, standardized to rosmarinic acid, at “one 167 mg daily dose”, and suited to capsules, gummies, dissolvable powders, ready-to-drink (RTD) beverages, and functional foods. The published acute data for sage extract at this dose range come from a five-period crossover in 20 adults over 65 that tested single doses of 167, 333, 666, and 1,332 mg [5]. In that trial, 333 mg improved secondary memory at every test time and improved accuracy of attention, while the other doses benefited to a lesser extent [5]. The same extract inhibited cholinesterase in vitro, which is mechanism evidence rather than a human effect [5]. Formulators building at 167 mg are therefore working from a dose arm that, for the extract tested, showed smaller benefits than 333 mg. No published trial has been identified as using sageXtra itself. The booth also listed NEM, Ovolux, and ESC eggshell membrane ingredients, curQ+ curcumin, and the distributed ingredients Bimuno, OraCMU, and Hymiome Post LB.

Seppic: Sepibright strawberry leaf extract

Seppic gave its new Sepibright a “Cognitive Sharpness and Well Aging” panel with the tagline “Lasting memory for a brilliant mind”. Sepibright is a hot-water extract of upcycled strawberry leaves (Fragaria Ă— ananassa) from Brittany, which All4Nutra covered at its Vitafoods Europe 2026 launch. Its trial randomized 109 adults aged 60 to 80 with self-reported memory complaints to 300 mg per day or placebo for 12 weeks [6]. That dose delivered about 20 mg polyphenols, 4 mg ellagitannins, and 3 mg salidroside per day. Mixed models showed no significant treatment-by-time interaction for the primary outcome, spatial working memory errors, or for the secondary outcomes [6]. Exploratory comparisons favored the extract on visual episodic memory errors at weeks 6 and 12 and on perceived stress at week 6. The authors call these findings hypothesis-generating, and Seppic funded the study [6].

Kyowa Hakko: Cognizin citicoline and Setria glutathione

Kyowa Hakko’s booth showed Cognizin citicoline under the line “Cognizin supports episodic memory”, with icons for water solubility, neutral taste, fermentation origin, vegetarian, and GRAS status. Citicoline (cytidine 5′-diphosphocholine) is the only ingredient in this recap with both an EU novel food authorisation and an EFSA health claim opinion [9,10]. In a 12-week trial in 100 healthy adults aged 50 to 85 with age-associated memory impairment, 500 mg per day improved episodic and composite memory, both secondary outcomes, while the primary outcome showed no significant group difference [8]. Kyowa Hakko Bio funded the trial [8].

Kyowa Cognizin at Supply Side Global 2026
Kyowa Cognizin at Supply Side Global 2026
Kyowa Cognizin at Suppyl Side Global 2026
Kyowa Cognizin at Suppyl Side Global 2026

 

 

 

 

 

 

 

 

 

 

In the EU, citicoline is an authorised novel food, limited in food supplements to 500 mg per day and not intended for children [9]. The European Food Safety Authority (EFSA) concluded in 2024 that a cause-and-effect relationship between citicoline and memory had not been established [10]. Setria reduced glutathione shared the booth for its 20th anniversary. No published human cognition trial of Setria was identified for this recap, so it sits outside the cognitive claims.

Rousselot: Nextida NxCogni collagen peptides

Rousselot, part of Darling Ingredients, launched Nextida NxCogni for “clarity and cognitive resilience” next to its Nextida GC peptide for glucose balance. The company describes NxCogni as a targeted collagen peptide composition with more than 10 “neurosupportive” peptides at concentrations over 100 times those in standard hydrolyzed collagen, designed as a non-stimulant at a low daily dose for capsules and tablets [7]. The booth panel itself stated that the positioning rests on preclinical research only and that clinical trials are ongoing. The peptide identities, the daily dose, and the preclinical data are not disclosed in the launch release [7]. For formulators, NxCogni is a pipeline ingredient rather than a claim-ready active; Rousselot also presented it in an October 29 session [1].

Unique Biotech: Cognisol psychobiotic

Unique Biotech’s wall headline read “Stable Probiotics with Proven Science and Claims”, and Cognisol carried the labels “psychobiotic”, “US patented blend”, “clinically demonstrated stress relief”, and “2 clinical studies”. The company lists 10 billion CFU per capsule of six strains, Bacillus coagulans Unique IS-2, Lactobacillus rhamnosus UBLR-58, Lactobacillus plantarum UBLP-40, Bifidobacterium lactis UBBLa-70, Bifidobacterium infantis UBBI-01, and Bifidobacterium breve UBBr-01, plus 250 mg L-glutamine, with strains selected for GABA (gamma-aminobutyric acid) production [11].

In a 28-day placebo-controlled trial in 80 university students facing exams, two capsules daily lowered perceived stress, anxiety, and depression scale scores and serum cortisol relative to placebo [12]. Three authors were Unique Biotech employees [12]. Only one published human trial could be matched to the booth’s “2 clinical studies”. The booth also showed Unique IS-2, UBBC-07 (Bacillus clausii), and the women’s health blend Provinorm. All4Nutra has also reviewed probiotics in mood and depression.

Bereum: beLP1 heat-treated kimchi postbiotic

beLP1, from the Korean company Bereum, is heat-treated Lactiplantibacillus plantarum isolated from kimchi, presented as “Gut health. Mood support.” at 10 mg per day, equal to 30 billion cells. The panel listed NDI, GRAS, FSSC 22000, halal, non-novel, non-GMO, and GMP credentials. As inanimate cells, beLP1 falls under the postbiotic definition of the International Scientific Association for Probiotics and Prebiotics (ISAPP), explained in All4Nutra’s postbiotics formulation guide.

Product belP1 by ...at Supply Side Global 2026
Product belP1 by …at Supply Side Global 2026

Its trial randomized 140 adults with excess weight (BMI 25 to 35) and gut discomfort to about 10 mg per day or placebo for 84 days [13]. Gastrointestinal symptom scores, the primary outcome, improved, and perceived stress, a secondary outcome, fell more than with placebo in the 103 per-protocol participants [13]. No trial with mood as the primary outcome was found, and Bereum funded the study [13]. With no viability to lose and a 10 mg inclusion, heat-treated cells are typically easier to place in gummies and beverages than live strains, a theme also covered in All4Nutra’s postbiotics preview for SupplySide Global 2026.

Nutraland USA: Vegadelight lichen vitamin D3

Nutraland USA presented Vegadelight, natural cholecalciferol extracted from wild-harvested reindeer lichen (Cladonia rangiferina), with “mood balance” among the benefits on its show leaflet. The leaflet listed powder at 85,000 and 100,000 IU/g, oil at 850,000 and 1,000,000 IU/g, conventional and USDA Organic grades, and a new microencapsulated “CleanShield” powder at 100,000 IU/g for multi-nutrient formulas. The company describes the ingredient as self-affirmed GRAS [15]. The same rack showed K2Go vitamin K2 (MK-7 from chickpea) as a D3 partner and Somato, a tomato-derived sleep ingredient.

Vegan Vitamin D3 by Nutraland USA
Vegan Vitamin D3 by Nutraland USA

For mood, the class evidence is weak in adults not selected for deficiency. In the VITAL-DEP trial, 2,000 IU per day of vitamin D3 for a median 5.3 years did not lower depression risk in 18,353 adults aged 50 and over [16]. All4Nutra’s vitamin D evidence update covers related mood and fatigue studies.

Herbal Treasure: private-label mushroom gummies

Herbal Treasure, a Chinese medicinal mushroom manufacturer, filled its table with “YOUR LOGO” private-label vegan gummies, including:

  • 7 Mushroom Complex, 4 Mushroom Complex, reishi, sea-salted reishi, turkey tail, chaga, cordyceps, tremella, Agaricus blazei, and Fomitopsis officinalis.
  • Non-mushroom gummies such as berberine, iron, tea-flavored, and shilajit.
  • Powders and drinks, including a “Daytime Cocoa Energy and Focus”, a mushroom-complex matcha, and mushroom coffees.

The company describes its gummies as pectin-based and lists its reishi gummies at more than 12% total polysaccharide and its lion’s mane gummies at more than 35.5% total beta-glucan, without stating whether the figure refers to the extract or the gummy, the assay, or the dose per gummy [18]. Total polysaccharide does not separate fungal beta-glucan from starch, a testing gap covered in All4Nutra’s mushroom quality coverage. Lion’s mane, the mushroom most often positioned for cognition, has small human trials, including a pilot in which a single 1.8 g dose produced faster Stroop performance at 60 minutes [19].

Formulation considerations for low-dose cognitive actives

At 10 to 500 mg per day, most actives in Table 1 fit a gummy or stick pack, which moves the formulation problem from bulk to stability, taste, and dose accuracy.

Table 2. Dose per serving and format watch-points for the showcased actives

Active Daily dose Formats named by supplier or booth Formulation watch-points
American ginseng extract 200 to 400 mg (licence) [4] Gummies, chewables, capsules Fits one gummy; flavor masking of ginsenoside bitterness likely needed
Lemon balm extract 300 mg [2] Capsule in trial [2] Single acute dose; no published repeated-dose trial located
Sage extract 167 to 333 mg [5] Capsules, gummies, dissolvable powders, RTD Label dose below the most consistent trial dose
Strawberry leaf extract 300 mg [6] Capsule in trial About 4 mg ellagitannins per dose; marker-level analytics needed
Citicoline 500 mg [8,9] Water-soluble, neutral taste EU cap of 500 mg/day in supplements [9]
Heat-treated L. plantarum 10 mg [13] Powder Very low inclusion; blend uniformity at a 10 mg inclusion
Vitamin D3 Microgram range Powder, oil, microencapsulated powder Metal ions and acidic pH degrade D3 [17]
Mushroom extracts 1.8 g in lion’s mane pilot [19] Pectin gummies, powders, coffees Trial doses exceed one gummy; assay method for beta-glucan

Vitamin D3 illustrates the multi-nutrient problem. In a systematic stability study, metal ions and acidic conditions had the main destabilizing effect on cholecalciferol in aqueous systems, and EDTA (ethylenediaminetetraacetic acid) was the most effective stabilizer [17]. Iron, copper, and zinc premixes and acidic pectin gummies are therefore likely hostile matrices, which is the case microencapsulated D3 grades are built for.

Gummy formats raise a separate dose ceiling. A single lion’s mane trial dose of 1.8 g [19] is more mushroom material than a single gummy typically carries, so a one-gummy serving commonly delivers a fraction of the studied dose. The USP chewable-gel parameters for water activity and pH summarised in All4Nutra’s dosage form guide to SupplySide Global 2026 apply to every gummy concept shown.

What claims cognitive and mood ingredients can carry in the US and EU

Cognitive and mood ingredients are sold in the US with structure/function statements. Under 21 CFR 101.93, such a statement must carry the FDA disclaimer, FDA must be notified within 30 days of first marketing, and a statement that the product diagnoses, treats, cures, mitigates, or prevents a disease is a disease claim [14]. Stratum’s sageXtra flyer and Rousselot’s NxCogni panel both carried the FDA disclaimer. Trial results in clinical populations, such as people with depression, therefore do not translate into supplement label language.

The EU is narrower. The list of authorised health claims allows “normal psychological function” for vitamins such as B6, B12, and C and for magnesium, and “normal cognitive function” for iodine, iron, and zinc [20]. Vitamin D carries no psychological or cognitive claim [20]. Botanical claims, including those for lemon balm, sage, and ginseng, are not on the authorised list, and EFSA found a memory claim for citicoline unsubstantiated [10,20]. Among the botanicals in this recap, Cereboost holds a Health Canada licence with cognitive claims [4].

Key takeaways

  • Cognitive and mood ingredients at SupplySide Global 2026 centered on low-dose, non-stimulant actives with acute-onset positioning, gut-brain biotics, and a collagen peptide its supplier calls the first designed for cognition [1,7].
  • The published trials of Zensera, Sepibright, and Cognizin each missed their primary outcome, with positive results limited to secondary or exploratory endpoints [2,6,8].
  • In one trial of a sage extract, the most consistent acute benefits appeared at 333 mg, twice the 167 mg dose on the sageXtra flyer [5].
  • Nextida NxCogni rests on undisclosed preclinical data, with clinical trials planned [7].
  • Heat-treated beLP1 is dosed at 10 mg per day, and its stress benefit was a secondary outcome [13].
  • Vitamin D3 at 2,000 IU per day did not lower depression risk in older adults, and metal ions and acidic pH are its main destabilizers in aqueous systems [16,17].

Frequently asked questions

Which cognitive and mood ingredients were shown at SupplySide Global 2026?

The All4Nutra team photographed Givaudan, Stratum Nutrition, Seppic, Kyowa Hakko, Rousselot, Unique Biotech, Bereum, Nutraland USA, and Herbal Treasure, covering botanical extracts, citicoline, collagen peptides, a probiotic blend, a postbiotic, lichen vitamin D3, and mushroom gummies. Education sessions covered brain-gut mood foods, sleep and stress, collagen peptides for cognition, and bacopa [1].

Which showcased ingredients have acute, same-day human data?

Cereboost, Zensera, and sage extract have single-dose trials. Cereboost improved working memory from 1 hour in a 32-person crossover [3], Zensera improved task-switching accuracy at 3 and 5 hours, although the groups already differed on this measure at baseline, while missing its calmness primary outcome [2], and sage extract at 333 mg improved memory and attention in 20 older adults [5].

Is a postbiotic like beLP1 easier to formulate than a live probiotic?

Generally yes, because heat-treated cells have no viability to protect during heat, moisture, or acidic processing. beLP1 is dosed at about 10 mg per day [13], so the main challenge shifts to uniform blending at very low inclusion. Mood positioning rests on a secondary stress outcome in an overweight adult population [13].

Can citicoline be sold in EU food supplements?

Yes. Citicoline is an authorised novel food in the EU, permitted in food supplements up to 500 mg per day and not intended for children [9]. During authorisation, some member states said they consider citicoline sodium salt products to be medicinal products, so national status needs checking [9]. No health claim is authorised: EFSA concluded in 2024 that a cause-and-effect relationship between citicoline and memory was not established [10].

Does vitamin D3 support mood in healthy adults?

A large trial in adults aged 50 and over, not selected for vitamin D deficiency, suggests not. VITAL-DEP gave 2,000 IU of vitamin D3 per day to 18,353 adults aged 50 and over for a median 5.3 years and found no reduction in depression risk [16]. The EU authorises no psychological or cognitive claim for vitamin D [20]. A mood positioning for a D3 ingredient therefore needs careful substantiation.


 

Sources

  1. SupplySide Global, SupplySide Global 2026 official session schedule, Informa Markets, 2026. https://attendees.supplysideshow.com/widget/event/supplyside-global-2026-1/plannings/RXZlbnRWaWV3XzEzMTcwMDA= (accessed 2026-11-01).
  2. Mathews I, Eastwood J, Bell L, Lamport D, Le Cozannet R, Fanca-Berthon P, Williams C, The acute effects of Zensera (Melissa officinalis L.) extract on mood and cognitive performance during cognitive overload: a randomised placebo-controlled, double-blind study in healthy young adults with moderate subjective stress, Therapeutic Advances in Psychopharmacology, 2026. https://doi.org/10.1177/20451253261415706 (accessed 2026-11-01).
  3. Scholey A, Ossoukhova A, Owen L, et al., Effects of American ginseng (Panax quinquefolius) on neurocognitive function: an acute, randomised, double-blind, placebo-controlled, crossover study, Psychopharmacology, 2010. https://doi.org/10.1007/s00213-010-1964-y (accessed 2026-11-01).
  4. Health Canada, Licensed Natural Health Products Database: Cereboost, NPN 80041222, Government of Canada, 2022. https://health-products.canada.ca/api/natural-licences/productlicence/?lang=en&type=json&id=80041222 (accessed 2026-11-01).
  5. Scholey AB, Tildesley NTJ, Ballard CG, Wesnes KA, Tasker A, Perry EK, Kennedy DO, An extract of Salvia (sage) with anticholinesterase properties improves memory and attention in healthy older volunteers, Psychopharmacology, 2008. https://doi.org/10.1007/s00213-008-1101-3 (accessed 2026-11-01).
  6. Dormal V, Dudonné S, Gombert C, et al., Enhanced memory function and reduced perceived stress in older adults with self-reported memory complaints following strawberry leaf extract supplementation: a randomized, double-blind, placebo-controlled study, Journal of Nutrition, Health and Aging, 2026. https://doi.org/10.1016/j.jnha.2026.100929 (accessed 2026-11-01).
  7. Darling Ingredients, Darling Ingredients introduces Nextida NxCogni, the first targeted collagen peptide designed to support clarity and cognitive resilience (press release, Business Wire), 2026. https://greenstocknews.com/news/nyse/dar/darling-ingredients-introduces-nextida-nxcogni-the-first-targeted-collagen-peptide-designed-to-support-clarity-and-cognitive-resilience (accessed 2026-11-01).
  8. Nakazaki E, Mah E, Sanoshy K, Citrolo D, Watanabe F, Citicoline and memory function in healthy older adults: a randomized, double-blind, placebo-controlled clinical trial, Journal of Nutrition, 2021. https://doi.org/10.1093/jn/nxab119 (accessed 2026-11-01).
  9. European Commission, Commission Implementing Decision 2014/423/EU authorising the placing on the market of citicoline as a novel food ingredient under Regulation (EC) No 258/97, Official Journal of the European Union, 2014. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32014D0423 (accessed 2026-11-01).
  10. EFSA Panel on Nutrition, Novel Foods and Food Allergens, ‘Citicoline’ and support of the memory function: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006, EFSA Journal, 2024. https://doi.org/10.2903/j.efsa.2024.8861 (accessed 2026-11-01).
  11. Unique Biotech, Cognisol: cognitive health product specification, Unique Biotech Ltd, 2026. https://www.uniquebiotech.com/human-health/cognitive (accessed 2026-11-01).
  12. Venkataraman R, Madempudi RS, Neelamraju J, et al., Effect of multi-strain probiotic formulation on students facing examination stress: a double-blind, placebo-controlled study, Probiotics and Antimicrobial Proteins, 2021. https://doi.org/10.1007/s12602-020-09681-4 (accessed 2026-11-01).
  13. Manoharan RK, Han KI, Lee Y, et al., Gut health and microbiome modulation by the heat-killed postbiotic beLP1 in adults with excess weight: a randomized, placebo-controlled trial, Frontiers in Nutrition, 2026. https://doi.org/10.3389/fnut.2026.1919277 (accessed 2026-11-01).
  14. US Food and Drug Administration, 21 CFR 101.93: Certain types of statements for dietary supplements, Electronic Code of Federal Regulations, 2026. https://www.ecfr.gov/current/title-21/chapter-I/subchapter-B/part-101/subpart-F/section-101.93 (accessed 2026-11-01).
  15. Nutraland USA, Vegadelight: natural vegan vitamin D3 from reindeer lichen, Nutraland USA Inc, 2026. https://www.vegadelight.com/ (accessed 2026-11-01).
  16. Okereke OI, Reynolds CF, Mischoulon D, et al., Effect of long-term vitamin D3 supplementation vs placebo on risk of depression or clinically relevant depressive symptoms and on change in mood scores: a randomized clinical trial, JAMA, 2020. https://doi.org/10.1001/jama.2020.10224 (accessed 2026-11-01).
  17. Temova Rakuša Ž, Pišlar M, Kristl A, Roškar R, Comprehensive stability study of vitamin D3 in aqueous solutions and liquid commercial products, Pharmaceutics, 2021. https://doi.org/10.3390/pharmaceutics13050617 (accessed 2026-11-01).
  18. Fujian Herbal Treasure Bioengineering, Private label mushroom gummies, Herbal Treasure, 2026. https://www.herbaltreasure.com/private-label-mushroom-gummies/ (accessed 2026-11-01).
  19. Docherty S, Doughty FL, Smith EF, The acute and chronic effects of lion’s mane mushroom supplementation on cognitive function, stress and mood in young adults: a double-blind, parallel groups, pilot study, Nutrients, 2023. https://doi.org/10.3390/nu15224842 (accessed 2026-11-01).
  20. European Commission, Commission Regulation (EU) No 432/2012 establishing a list of permitted health claims made on foods, other than those referring to the reduction of disease risk and to children’s development and health, Official Journal of the European Union, 2012. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32012R0432 (accessed 2026-11-01).

Disclaimer

These statements have not been evaluated by the Food and Drug Administration. This information is provided for dietary supplement industry professionals and is not intended to diagnose, treat, cure, or prevent any disease.

Tags: nutraceuticals
Previous Post

CollaSwiss® Launches First Collagen Peptides from Switzerland

Next Post

Postbiotics and pasteurized Akkermansia at SupplySide Global 2026

SupplySide Global 2026 Recap

SupplySide Global 2026 Recap
SupplySide Global 2026 Recap

LATEST NEWS ON ALL4NUTRA

Biotics 1

Postbiotics and pasteurized Akkermansia at SupplySide Global 2026

Cognitive Health

Cognitive and Mood Ingredients at SupplySide Global 2026: Recap

Young,Woman,Dissolving,Collagen,Powder,In,Glass,Of,Water,,Preparing

CollaSwiss® Launches First Collagen Peptides from Switzerland

CYCLODEXTRIN COMPLEXES

Berberine Cyclodextrin Complexes as an example for the use of cyclodextrins in nutraceuticals

YOU MIGHT ALSO LIKE

Supply Side Global 2026 – curated supplier overview

Supply Side Global 2026 – curated supplier overview

Longevity

Ubiquinol, NMNH, and NAD+: longevity science at SupplySide Global 2026

AI formulation solutions - Vitafoods

AI Formulation Tools Reshaping the Nutraceutical Industry in 2026

Shatavari

Why shatavari is trending at SupplySide Global 2026

Next Post
Biotics 1

Postbiotics and pasteurized Akkermansia at SupplySide Global 2026

HOME

SHOP

PRODUCT INQUIRY

NEWS

WEBINARS

COOKIE SETTINGS

PRIVACY POLICY

IMPRINT

KNOW HOW

BASICS

EXCIPIENTS

INGREDIENTS & SUPPLEMENTS

PRODUCTION PROCESS

SOURCING

SUPPLIERS

CONSULTANTS

SECTORS

 BONE & JOINT HEALTH

CARDIOVASCULAR HEALTH

BRAIN HEALTH

IMMUNITY & GUT HEALTH

SKIN & BEATUY

SPORTS NUTRITION

WEIGHT MANAGEMENT & METABOLISM SUPPORT

APPLICATIONS

CAPSULES

EFFERVESCENT

GRANUELS

GUMMY

LOZENGES

ORAL THIN FILMS

SACHETS

SOFT CAPSULES

TABLETS

NEWS

Postbiotics and pasteurized Akkermansia at SupplySide Global 2026

Cognitive and Mood Ingredients at SupplySide Global 2026: Recap

CollaSwiss® Launches First Collagen Peptides from Switzerland

Berberine Cyclodextrin Complexes as an example for the use of cyclodextrins in nutraceuticals

Glatt at FI Europe: How Glatt technologies improve food ingredients

ADM and Asahi Expand Innovation and Applications for Lactobacillus gasseri CP2305 Postbiotic

© 2025 - ALL4NUTRA - All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Shop
  • News
  • Know How
  • Applications
  • Sectors
  • Sourcing
  • Webinars
  • Product Inquiry